ENDOVASCULAR ANEURYSM REPAIR MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

The Endovascular Aneurysm Repair Market is estimated to be valued at USD 3.5 Bn in 2026 and is expected to reach USD 6.5 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 6.3% from 2026 to 2033. The market is undergoing a major transformation mainly driven by the technological advancements in minimally invasive procedures, an aging population, and the rising incidence of vascular diseases. The increasing adoption of stent grafts, which offer improved patient outcomes, is a key factor in the market’s growth. EVAR provides patients with the benefit of reduced recovery times and fewer complications compared to traditional open surgeries. In addition, the healthcare providers are embracing advanced imaging systems, which allow for more precise treatment, especially in complex aneurysms, thus enhancing procedural success rates.

The market is also growing with the innovations like 3D imaging, robotic-assisted navigation, and improved stent designs which help in better customization of treatment for individual patients. The integration of post-operative monitoring and follow-up care is also boosting patient satisfaction as well as long-term outcomes. In addition, as awareness grows regarding the benefits of EVAR, more patients are opting for this minimally invasive alternative. These advancements are revolutionizing vascular care, thereby leading to a more personalized approach to aneurysm treatment.

Market Dynamics

The Endovascular Aneurysm Repair (EVAR) market is expanding at a rapid pace. The growth is mainly owing to the increasing adoption of minimally invasive procedures and the growing number of vascular diseases. As the global population ages, the demand for treatments that offer faster recovery times and fewer complications compared to traditional surgeries is increasing. EVAR, which utilizes stent grafts to repair aneurysms through small incisions, offers substantial advantages over open surgeries. These benefits, along with advancements in stent graft technology like improved durability and biocompatibility are encouraging more patients to opt for this procedure, thereby fueling market growth.

The technological advancements also play a crucial role in the growth of the EVAR market. The introduction of 3D imaging, real-time diagnostic tools, and robotic-assisted surgery systems is improving the precision of these procedures. These innovations not only enhance the safety of EVAR but also reduce the likelihood of complications and shorten recovery times. In addition, the integration of telemedicine and remote monitoring solutions allows healthcare providers to follow up with patients more effectively, thus ensuring better post-operative care and long-term outcomes.

Furthermore, the shift toward outpatient care and cost-effective treatment options is contributing to the increased adoption of EVAR procedures. Several healthcare systems are embracing this model, which focuses on reducing hospital stays and associated costs. As healthcare providers continue to invest in advanced technologies, and as patient awareness of EVAR's advantages grows, the market is expected to experience sustained growth. With further innovation in medical devices and improved procedural techniques, the EVAR market is poised to offer safer, more efficient, and accessible solutions for patients across the world.

Key Features of the Study

• This report provides in-depth analysis of the Endovascular Aneurysm Repair Market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the Endovascular Aneurysm Repair Market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Medtronic plc. Cook Medical, Gore Medical, B. Braun Melsungen AG, Terumo Corporation, Boston Scientific Corporation, Abbott Laboratories, Volcano Corporation, C.R. Bard, Spectranetics International BV, Cordis Corporation (Johnson and Johnson Co.), and St. Jude Medical Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The Endovascular Aneurysm Repair Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Endovascular Aneurysm Repair Market

Market Segmentation (Version-2026)

• By Product Type (Revenue, USD Bn, 2021-2033)
  • Fenestrated Stent Graft
  • Adjunctive Stent Graft
  • Branched Stent Graft
  • Others
• By Indication (Revenue, USD Bn, 2021-2033)
  • Abdominal Aortic Aneurysm (AAA)
  • Thoracic Aortic aneurysm (TAA)
    • Descending Aortic Aneurysm
    • Ascending Aortic Aneurysm
• By End User (Revenue, USD Bn, 2021-2033)
  • Hospitals
  • Ambulatory Care Services
  • Specialty Clinics
• By Region (Revenue, USD Bn, 2021-2033)
  • North America
    
    • U.S.
    • Canada
  • Latin Americ
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    •  India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  •  Middle East
    • GCC
    •  Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Central Africa
    • North Africa
• Key Players
  • Medtronic plc.
  • Cook Medical
  • Gore Medical
  • Braun Melsungen AG
  • Terumo Corporation
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Volcano Corporation
  • C.R. Bard
  • Spectranetics International BV
  • Cordis Corporation (Johnson and Johnson Co.)
  • Jude Medical Inc.